Aprepitant Metabolite C | 
    |
| Synonyms: Aprepitant M2 Metabolite (1R, 2R, 3S)-Isomer; 2-(R)-[1-(R)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine; Aprepitant-M2; (2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)morpholine; | |
| Cat. No.: A66227 | CAS No.: 171338-27-5,171482-05-6(HCl Salt) | 
| MDL.: | Formula: C20H18F7NO2 | 
| F.W.437.35 | Purity: 99% | 
| Storage: -20°C Freezer | |
|   | |
             | Catalog Number: | A66227 | CAS No.: | 171338-27-5,171482-05-6(HCl Salt) | |
| MDL: | Formula: | C20H18F7NO2 | ||
| F.W.: | 437.35 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | Yellow Low Melting Solid | M.P.: | N/A | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | Chloroform, Dichloromethane, Methanol | ||
| Storage: | -20°C Freezer | Category: | Reference Standard | |
| Reference: | Ballard, T., et al.: Eur. J. Pharmacol., 412, 255 (2001), Campos, D., et al.: J. Clin. Oncol., 19, 1759 (2001), Severini, C., et al.: Pharmacol. Rev., 54, 285 (2002), | |||
| Application: | A metabolite of Aprepitant. | |||
| Category: | Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals | |||








